ANALISE BETKER: Open Payments
NPI 1578931689 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 16 payments from 8 companies in 2025. Trend: 2023 $718 · 2024 $1,514 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $108 |
| Amgen Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Astellas Pharma US Inc | 1 | $21 |
| PFIZER INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: Ozempic, OTEZLA, Auvelity, Wegovy, Veozah, NURTEC ODT, MOUNJARO, GARDASIL 9.
Industry payments across MI — which companies pay providers there.
